Etoglucid: Difference between revisions
Content deleted Content added
m Task 18 (cosmetic): eval 1 template: del empty params (2×); cvt lang vals (1×); |
Astralwither (talk | contribs) No edit summary |
||
| Line 54: | Line 54: | ||
| synonyms = <small>diglycidyltriethylene glycol</small> |
| synonyms = <small>diglycidyltriethylene glycol</small> |
||
}} |
}} |
||
'''Etoglucid''' is a drug used in [[chemotherapy]].<ref name="pmid8178408">{{cite journal |vauthors=Flamm J, Donner G, Bucher A, Höltl W, Albrecht W, Havelec L |title=[Topical immunotherapy (KLH) vs. chemotherapy (Ethoglucid) in prevention of recurrence of superficial bladder cancer. A prospective randomized study] |language=de |journal=Urologe A |volume=33 |issue=2 |pages=138–43 |date=March 1994 |pmid=8178408 }}</ref> |
'''Etoglucid''' is a drug used in [[chemotherapy]].<ref name="pmid8178408">{{cite journal |vauthors=Flamm J, Donner G, Bucher A, Höltl W, Albrecht W, Havelec L |title=[Topical immunotherapy (KLH) vs. chemotherapy (Ethoglucid) in prevention of recurrence of superficial bladder cancer. A prospective randomized study] |language=de |journal=Urologe A |volume=33 |issue=2 |pages=138–43 |date=March 1994 |pmid=8178408 }}</ref> It is an [[epoxide]] compound.<ref>{{Cite web|last=PubChem|title=Etoglucid|url=https://pubchem.ncbi.nlm.nih.gov/compound/16058|access-date=2021-03-02|website=pubchem.ncbi.nlm.nih.gov|language=en}}</ref> |
||
==References== |
==References== |
||
Revision as of 18:24, 2 March 2021
 | |
| Clinical data | |
|---|---|
| Other names | diglycidyltriethylene glycol |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.016.168 |
| Chemical and physical data | |
| Formula | C12H22O6 |
| Molar mass | 262.29948 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
Etoglucid is a drug used in chemotherapy.[1] It is an epoxide compound.[2]
References
- ^ Flamm J, Donner G, Bucher A, Höltl W, Albrecht W, Havelec L (March 1994). "[Topical immunotherapy (KLH) vs. chemotherapy (Ethoglucid) in prevention of recurrence of superficial bladder cancer. A prospective randomized study]". Urologe A (in German). 33 (2): 138–43. PMID 8178408.
- ^ PubChem. "Etoglucid". pubchem.ncbi.nlm.nih.gov. Retrieved 2021-03-02.
 | This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |